Results
1 -
9 of
9M. Kido, K. Kondo, H. Yamashita and H. Ogawa.
Structure of OPC-21268, Acta Cryst. (1994). C50, 302-304Â Â Â Â OPC-21268, an Orally Effective, Nonpeptide Arginine Vasopressin V1 Receptor Antagonist Reduces Vasogenic Brain Edema, Brain Edema X Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist, Naunyn-Schmiedeberg's Archives of Pharmacology Vasotocin- and mesotocin-induced increases in short-circuit current across tree frog skin, Journal of Comparative Physiology B Effects of arginine vasotocin and mesotocin on the activation and development of amiloride-blockable short-circuit current across larval, adult, and cultured larval bullfrog skins, Journal of Comparative Physiology B Protective Effect of a Vasopressin-1 Selective Antagonist, OPC-21268, Against Ethanol-Induced Damage of The rat Gastric Wall, Digestive Diseases and Sciences Arginine vasopressin increases the rate of protein synthesis in isolated perfused adult rat heart via the V1 receptor, Molecular and Cellular Biochemistry OPC-21268, Inpharma Weekly